Alfa is uniquely positioned in the global pharmaceutical market as an exclusive supplier of active pharmaceutical ingredients (APIs) and finished pharmaceutical & nutraceutical products.
The firm’s horizontal and vertical integration in selling and marketing capabilities enable our pharmaceutical partners and global healthcare markets to receive medicine more swiftly and catering to wider populations in need.
Alfa pharma partners exclusively provides global pharmaceutical industry with the following reliable CGMP quality-value driven solutions in :
- Active pharmaceutical ingredients (API)
- Finished products
Highest quality of Active Pharmaceutical Ingredients
Delivering the broader portfolio in the active pharmaceutical ingredients (API) industry.
The partners of Alfa pharma supply high quality APIs to various markets worldwide. More than 100 quality APIs are manufactured at various state-of-the-art production facilities complying with all major industry standards. Alfa is wholly committed to environmental, health and safety (EHS) matters in all aspects of the business to ensure suppliers are sustainable.
At Alfa, we take tremendous pride in our collaborations and we view our partners’ success as our own. Our comprehensive expertise and knowledge provides significant value to our partners. We devote all our resources to help them deliver high-quality generic and innovative products to the market rapidly and effectively. By continuously nurturing these partnerships through close working relationships, the partners of Alfa offer superior product quality and end-to-end support. This includes designed personnel assigned to each customer of ours, highly-responsive customer service representatives, logistical support, as well as R&D, QA, RA, IP and marketing personnel.
Our strong partnerships with suppliers enable timely introduction of new products to market, generating a steady flow of APIs.
Additionally, the experts from our partners’ RA and QA teams maintain the utmost global standards of quality and regulatory compliance, with unparalleled IP support providing our customers with the freedom to operate efficiently, and providing them with a competitive edge.
Furthermore, from-time-to-time, Alfa pharma proactively initiates unannounced product review with our suppliers. This ensures our partners to be prepared for frequent FDA, MHRA/TGA, and national MOH audits.
Providing far more than APIs, Alfa pharma is committed to our business partner success.
List of Active Pharmaceutical Ingredients (APIs)
# | API | Therapeutic Area | Status |
1 | Allopurinol | Antiurolithic | CEP |
2 | Alogliptin Benzoate | Antidiabetic | Under development |
3 | Amantadine Hydrochloride | Antiviral agent | USP, JP, IP |
4 | Anastrozole | Aromatase Inhibitor | CEP |
5 | Antazoline Hydrochloride | Ophthalmology | DMF, small molecule |
6 | Antazoline Phosphate | Ophthalmology | DMF, small molecule |
7 | Antazoline Sulfate | Ophthalmology | DMF, small molecule |
8 | Apixaban | Anticoagulant | Under development |
9 | Apremilast | Anti-arthritic/Anti-psori | Under Development |
10 | Aprepitant | Anti-emetic | USDMF |
11 | Armodafinil | Eugeroic | USDMF |
12 | Azacytidine | Myelodysplastic syndrom | DMF, EDMF, CEP |
13 | Azelastine Hydrochloride | Antihistaminic | Under development |
14 | Baclofen | Muscle relaxant | USDMF |
15 | Bepotastine Besilate | Antihistaminic | Under development |
16 | Besifloxacin Hydrochloride | Bacterial Conjunctivitis | Under development |
17 | Betaxolol Hydrochloride | Antiglaucoma | CEP |
18 | Bisoprolol Fumarate | Anti-hypertensive | US-DMF, CEP, ASMF |
19 | Bleomycin Sulphate | Anti-Cancer | DMF, EDMF, CEP |
20 | Bortezomib | Anti-Cancer | DMF, EDMF, CEP |
21 | Brimonidine Tartrate | Antiglaucoma | CEP |
22 | Brinzolamide | Antiglaucoma | EU DMF |
23 | Bromfenac Sodium | Antiinflammatory | Under development |
24 | Glucagon | Antidiabetes | DMF, Peptide |
25 | Busulfan | Antineoplastic | CTD, Tech pack |
26 | Cabazitaxel | Anti-Cancer | DMF, EDMF, CEP |
27 | Gonadorelin Acetate | Oncology | CEP, DMF, Peptide |
28 | Camylofin dihydrochloride | Anti-spasmodic | 0 |
29 | Canagliflozin | Antidiabetic | Under development |
30 | Canagliflozin Hemihydrate | Anti-diabetic | Under Development |
31 | Capecitabine | Anti-Cancer | DMF, EDMF, CEP |
32 | Atosiban | Preproductive medicine | DMF, Peptide |
33 | Carboplatin | Anti-Cancer | DMF, EDMF, CEP |
34 | Carfilzomib | Multiple myeloma | DMF, EDMF, CEP |
35 | Carmustine | Antineoplastic | CTD, Tech pack |
36 | Carvedilol | Antihypertensive | CEP, DMF |
37 | Celecoxib | Anti-inflammatory | CEP, DMF |
38 | Chlorzoxazone | Muscle Relaxant | CEP, DMF |
39 | Cinacalcet HCL | Calcimimetic | USDMF |
40 | Cisatracurium | Neuromuscular | DMF, EDMF, CEP |
41 | Cisplatin | Anti-Cancer | DMF, EDMF, CEP |
42 | Clobazam | Anti-Convulsant | USDMF |
43 | Cyclophosphamide | Anti-Cancer | DMF, EDMF, CEP |
44 | Dabigatran Etexilate Mesylate | Anti-Coagulant | USDMF |
45 | Dapagliflozin | Antidiabetic | Under development |
46 | Dapagliflozin (S)-Propanediol Mo Anti-diabetic | Under Development | |
47 | Daunorubicin | Anti-Cancer | DMF, EDMF, CEP |
48 | Deferasirox | Iron Chelator | USDMF |
49 | Goserelin Acetate | Oncology | CEP, DMF, Peptide |
50 | Desvenlafaxine Succinate Monoh | Anti-depressant | Under Development |
51 | Dexlansoprazole | Anti-ulcerant | Under Development |
52 | Dextromethorphan Hydrobromi Antitussive | USP, IP | |
53 | Dicycloverine / Dicyclomine HCL | Antispasmodic | CEP, DMF |
54 | Diltiazem Hydrochloride | Anti-hypertensive | US-DMF, CEP, ASMF |
55 | dl-Cloprostenol Sodium | Luteolytic agent | USDMF |
56 | Docetaxel Anhydrous | Anti-Cancer | DMF, EDMF, CEP |
57 | Docetaxel Trihydrous | Anti-Cancer | DMF, EDMF, CEP |
58 | Domperidone | Antiemetic | CEP, DMF |
59 | Donepezil Hydrochloride | Anti-alzheimer’s | USDMF |
60 | Dorzolamide Hydrochloride | Anti-Glaucoma | CEP, DMF |
61 | Doxorubicin | Anti-Cancer | DMF, EDMF, CEP |
62 | Dronedarone Hydrochloride | Anti-arrhythmic | USDMF |
63 | Droxidopa | Anti-parkinson | Under Development |
64 | Empagliflozin | Anti-diabetic | Under Development |
65 | Ephedrine Hydrochloride | Bronchodilator | USP, IP |
66 | Epirubicin | Anti-Cancer | DMF, EDMF, CEP |
67 | Epothilone | Anti-Cancer | DMF, EDMF, CEP |
68 | Escitalopram Oxalate | Anti-depressant | CEP, DMF |
69 | Etoposide | Anti-Cancer | DMF, EDMF, CEP |
70 | Everolimus | Anti-Cancer | DMF, EDMF, CEP |
71 | L-cysteine Hydrochloride Monohydrate | CEP, DMF, small molecule | |
72 | Febuxostat | Hyperuricemia | Under development |
73 | Fludarabine Phosphate | Anti-Cancer | DMF, EDMF, CEP |
74 | Folic Acid | Hematinic | EU CEP |
75 | Fosaprepitant Dimeglumine | Anti-emetic | USDMF |
76 | Gliclazide | Antidiabetic | CEP |
77 | Glimepiride | Antidiabetic | CEP |
78 | L-Ornithine a-ketogultarate Monohydrate | DMF, small molecule | |
79 | Lanreotide | Oncology | DMF in progress |
80 | Leuprolide Acetate | Oncology | CEP, DMF, Peptide |
81 | Granisetron HCI | Anti-Cancer | DMF, EDMF, CEP |
82 | Imatinib Mesylate | Tyrosine Kinase Inhibitor | CEP, USDMF, CTD, Tech pack |
83 | Irbesartan | Anti-hypertensive | CEP, DMF |
84 | Irinotecan HCl | Anti-Cancer | DMF, EDMF, CEP |
85 | Iron Sucrose | Iron deficiency | DMF, EDMF, CEP |
86 | Ivabradine | Anti-anginal | Under Development |
87 | Ivacaftor | Cystic Fibrosis | Under Development |
88 | Ixabepilone | Anti-Cancer | DMF, EDMF, CEP |
89 | Ketoconazole | Anti-fungal | US-DMF, CEP, ASMF |
90 | Bivalurudin | Cardiovascular diseases | DMF, Peptide |
91 | Buserelin | Oncology | CEP, DMF, Peptide |
92 | Lacosamide | Analgesic, Anticonvulsan | EU DMF |
93 | Octreotide Acetate | Oncology | DMF, Peptide |
94 | Ledipasvir | Hepatitis C | CTD, Tech pack |
95 | Lenalidomide | Thalidomide | DMF, EDMF, CEP |
96 | Lercanidipine | Anti-hypertensive | 0 |
97 | Letrozole | Aromatase Inhibitor | CEP, USDMF, CTD, Tech pack |
98 | Propofol | Sedation | CEP, DMF, small molecule |
99 | Levofloxacin Hemihydrate | Fluoroquinolone | USP, IP |
100 | Levofloxacin Hydrochloride | Fluoroquinolone | CP |
101 | Linagliptin | Anti-diabetic | Under Development |
102 | Losartan Potassium | Anti-hypertensive | CEP, DMF |
103 | Lurasidone Hydrochloride | Anti-psychotic | USDMF |
104 | Marbofloxacin | Antibiotic | EP |
105 | Mebeverine Hydrochloride | Anti-spasmodic | ASMF |
106 | Metformin DC | Antidiabetic | EU CEP |
107 | Metformin HCL | Antidiabetic | EU CEP |
108 | Mirabegron | Urinary Incontinence | Under development |
109 | Misoprostol | Anti-ulcerant | US-DMF, CEP, ASMF |
110 | Mitomycin C | Anti-Cancer | DMF, EDMF, CEP |
111 | Mitoxantrone HCI | Anti-Cancer | DMF, EDMF, CEP |
112 | Monosulfiram | Ectoparasiticide | 0 |
113 | Moxifloxacin Hydrochloride | Antibacterial | Under development |
114 | Nedaplatin | Anti-Cancer | DMF, EDMF, CEP |
115 | Neostigmine Methylsulfate | Anticholinesterase | Under development |
116 | Somatostatin | Others | CEP, DMF, Peptide |
117 | Ofloxacin | Fluoroquinolone | USP, EP, JP, IP |
118 | Olopatadine Hydrochloride | Antihistaminic | EU DMF |
119 | Ondansetron HCL | Antiemetic | CEP, USDMF, CTD, Tech pack |
120 | Oxaliplatin | Anti-Cancer | DMF, EDMF, CEP |
121 | Paclitaxel | Anti-Cancer | DMF, EDMF, CEP |
122 | Paliperidone | Anti-psychotic | Under Development |
123 | Paliperidone Palmitate | Anti-psychotic | Under Development |
124 | Palonosetron HCL | Antiemetic | DMF, EDMF, CEP |
125 | Papaverine Hydrochloride | Antipasmolytic | USP, IP |
126 | Pemetrexed Disodium | Anti-Cancer | DMF, EDMF, CEP |
127 | Perindopril Tert-butylamine | ACE Inhibitor | US-DMF, CEP, ASMF |
128 | Pipotiazine Palmitate | Antipsychotic | DMF, EDMF, CEP |
129 | Pirarubicin | Anti-Cancer | DMF, EDMF, CEP |
130 | Pomalidomide | Anti-Angiogenic | USDMF, CTD, Tech pack |
131 | Posaconazole | Antifungal | Under development |
132 | Pramipexole Dihydrochloride M Anti-parkinson | US-DMF, CEP, ASMF | |
133 | Pregabalin | Anticonvulsant | CEP, DMF |
134 | Carbidopa | Epilepsy & Parkinson’s | CEP, DMF, small molecule |
135 | Pseudoephedrine Hydrochloride Decongestant | USP, IP | |
136 | Pseudoephedrine Sulfate | Decongestant | USP |
137 | Quetiapine Fumarate | Antipsychotic | CEP |
138 | Raloxifene Hydrochloride | Anti-estrogen | Under Development |
139 | Ranolazine | Anti-anginal | Under Development |
140 | Rasagiline Mesylate | Antiparkinsonian | Under development |
141 | Rasagiline Tartrate | Antiparkinsonian | Under development |
142 | Regadenoson Monohydrate | Cardiovascular | Under Development |
143 | Rivaroxaban | Anti-Coagulant | USDMF |
144 | Rizatriptan Benzoate | Anti-Migraine | CEP, USDMF, CTD, Tech pack |
145 | Rufinamide | Anticonvulsant | Under development |
146 | Salmeterol Xinafoate | Antiasthmatic | CEP, USDMF, CTD, Tech pack |
147 | Silymarin | Liver diseases | DMF, EDMF, CEP |
148 | Sitagliptin | Antidiabetic | Under development |
149 | Solifenacin succinate | Antimuscarinic | CEP, DMF |
150 | Teriparatide Acetate | Osteoporosis | DMF, Peptide |
151 | Sorafenib Tosylate | Tyrosine Kinase Inhibitor USDMF, CTD | |
152 | Spironolactone | Diuretics | CEP, ASMF |
153 | Sugammadex Sodium | General anaesthesia | Under Development |
154 | Telmisartan | Anti-hypertensive | CEP, DMF |
155 | Teriflonomide | CNS Agent | USDMF, CTD, Tech pack |
156 | Tetracosactide | Oncology | DMF, Peptide |
157 | Tetrabenazine | Hyperkinetic Movement | Under Development |
158 | Trimetazidine Dihydrochloride | Cardiovascular diseases | CEP, small molecule |
159 | Thiotepa | Antineoplastic | CTD, Tech pack |
160 | Ticagrelor | Anti-coagulant | Under Development |
161 | Trazodone Hydrochloride | Anti-depressant | USDMF, ASMF |
162 | Trientine Dihydrochloride | Chelating compound | Under Development |
163 | Desmopressin Acetate | Others | CEP, DMF, Peptide |
164 | Etomidate | Hypnotic | DMF, Peptide |
165 | Exenatide Acetate | Antidiabetes | DMF, Peptide |
166 | Varenicline Tartrate | Nicotinic antagonist | Under Development |
167 | Verapamil Hydrochloride | Anti-hypertensive | US-DMF, CEP, ASMF |
168 | Vigabatrin | Anti-convulsant | Under Development |
169 | Vildagliptin | Antidiabetic | Under development |
170 | Vinorelbine Bitartrate | Anti-Cancer | DMF, EDMF, CEP |
171 | Vortioxetine Hydrobromide | Anti-depressant | Under Development |
172 | Zoledronic Acid | Anti-Osteoporosis | USDMF, CEP, CTD, Tech pack |
173 | Zolmitriptan | Anti-Migraine | USDMF, CTD, Tech pack |
A broad portfolio of finished products – An unique opportunity for our partners
Alfa pharma complies with all the quality standards.
The broad portfolio has an unprecedented impact on healthcare in global markets.
Not only does Alfa have a comprehensive understanding of the international markets, Alfa also ensures that products are tailored to the needs of local patients, physicians and consumers. We have an unparalleled ability to collaborate with high caliber partners to commercialize pharmaceutical and nutraceutical products.
Building on the remarkable record of achievement from its founders, Alfa continues to pursue a rich future in pharmaceuticals and nutraceuticals by putting a spotlight on patient needs, convenience, improved compliance, safety, and efficacy.
List of Prescription Drugs
# | Product(Ref.product) | Therapy | Strength/Release | Dosage form | Status |
1 | Amikacin | Antibiotics | 500mg/2ml | Injectable | EU CTD, Reg. in UK (national) |
2 | Amitriptylin | Central Nervous System | 10, 25, 50mg | Tablet | EU CTD, RMS: UK, CMS: DE |
3 | Amoxicillin | Antibiotics | 250, 500mg | Capsule | EU CTD, Reg. in EU |
4 | Apixaban | Cardiovascular System | 2.5, 5mg | Tablet | EU CTD, EU – Release |
5 | Aripiprazole | Central Nervous System | 5, 10, 15, 20mg | Tablet | EU CTD, EU – Release |
6 | Aripiprazole | Central Nervous System | 5, 10, 15, 30mg | Tablet | EU CTD, DCP: DE, IT |
7 | Atorvastatin | Cardiovascular System | 10, 20, 40mg | Tablet | EU CTD, Reg. in EU |
8 | Aztreonam | Antibiotics | 1000mg | Injectable | EU CTD, EU – Release |
9 | Benfo. + Vit B6 + Vit B12 | Anti-diabetic | 40+90+250 mcg | Tablet | EU-COPP, EU-MfG. |
10 | Bimatoprost (0.01%) | Ophthalmology | 0.01% (3ml) | Eye Drop | EU CTD, RMS: PL, CMS: PL |
11 | Bimatoprost (0.03%) | Ophthalmology | 0.03% (3ml) | Eye Drop | EU CTD, RMS: PL, CMS: PL |
12 | Bimatoprost Eye Drops | Ophthalmology | 0.3mg/ml | Eye Drop | EU CTD, RMS: UK, CMS: BE, ES, IT, FR |
13 | Bleomycin | Oncology | 15000 IU | Injectable | EU-CTD |
14 | Bortezomib | Oncology | 3.5mg | Injectable | EU CTD, Reg. in DE |
15 | Brimonidine Tartarate 0.2% |
Ophthalmology | 80, 120mg | Eye Drop | EU CTD, DCP Ongoing (DE) |
16 | Brimonidine Tartarate 0.2% |
Ophthalmology | 0.2% (5/10ml) | Eye Drop | EU CTD, RMS:NL, CMS: DE, UK |
17 | Carbocisteine | Productive Cough | 375mg | Capsule | EU CTD, RMS: UK, CMS: IE |
18 | Carbocisteine | Productive Cough | 250mg/ml | Syrup | EU CTD, Reg. in UK (national) |
19 | Cefoperazone+ Sulbactum |
Cephalosporins | 1000, 2000mg | Injectable | EU CTD, EU – Release |
20 | Celecoxib | Pain Management | 100, 200mg | Capsule | EU CTD, RMS: UK, CMS: DE |
21 | Celecoxib | NSAID | 100, 200 mg | Capsule | MA (UK,DE,IT,ES) |
22 | Cepepime+Sulbactum | Cephalosporins | 1.5, 3mg | Injectable | EU CTD, EU – Release |
23 | Cetirizine Tablets | Anti-histamine | 10mg | Tablet | EU CTD, EU – Release |
24 | Clindamycin Hcl | Antibiotics | 75, 150, 300mg | Capsule | EU CTD, Reg. in UK (national) |
25 | Clopidogrel | Anti-platelet | 75 mg | Tablet | MA (UK,DE,IT) |
26 | Co-Amoxiclav | Antibiotics | 125+31.25mg/5ml, 250+62.5mg/5ml |
Suspension | EU CTD, Reg. in NL (national) |
27 | Co-Amoxiclav | Antibiotics | 200+28.5mg/5ml, 400+57mg/5ml |
Suspension | EU CTD, RMS: UK, CMS: IE, PT |
28 | Co-Amoxiclav | Antibiotics | 375, 625, 1000mg | Tablet | EU CTD, RMS: UK, CMS: IE, SE |
29 | Colchicine | Antibiotics | 500mcg | Tablet | MA in 4 EU |
30 | Daclatasvir | Antiviral (Hepatitis C) | 60mg | Tablet | EU CTD, EU – Release |
31 | Donepezil | Anti-psychotic | 5mg, 10mg | Tablet | MA (UK,DE,IT) |
32 | Dorzolamide +Timolol | Ophthalmology | 20+5mg/ml | Eye Drop | EU CTD, RMS: PT, CMS: DE & FR |
33 | Dorzolamide Hcl | Ophthalmology | 2% (5mg/10ml) | Eye Drop | EU CTD, RMS: NL, CMS: UK, HU, DE |
34 | Dorzolamide Hcl+Timolol Maleate |
Ophthalmology | 2%+0.5% (5mg/10ml) | Eye Drop | EU CTD, RMS: CZ, CMS: NL, DE, PL, UK, SK, HU |
35 | Duloxetine | Central Nervous System | 30, 60mg | Capsule | EU CTD, Reg. in DE |
36 | Duloxetine | Central Nervous System | 20, 40mg | Capsule | EU CTD, EU – Release |
37 | Enoxaparin Pfs | Cardiovascular System | 20mg/0.2ml, 40mg/0.4ml, 60mg/0.6ml, 80mg/0.8ml | Injectable | EU CTD, EU – Release |
38 | Escitalopram | Anti-depressant | 5, 10, 20mg | Tablet | MA (UK,DE,IT) |
39 | Escitalopram Oxalate | Central Nervous System | 10, 20mg | Tablet | EU CTD, Reg. in AT |
40 | Etoricoxib | Pain Management | 30, 60, 90, 120mg | Tablet | EU CTD, RMS: ES, CMS: DE, IE, IT, MT, PT & RO |
41 | Fosfomycin | Urology | 3g | Sachets | EU-COPP, EU-MfG. |
42 | Gabapentin | Central Nervous System | 100, 300, 400, 600, 800mg |
Tablet | EU CTD, RMS: UK, CMS: DE |
43 | Imatinib Mesilate | Oncology | 100, 200, 400 mg | Capsule | EU-COPP, EU-MfG. |
44 | Imipenem+Cilastatin | Carbapenems | 500+500mg | Injectable | EU CTD, Reg. in DE |
45 | Irbesartan | Cardiovascular System | 75, 150, 300mg | Tablet | EU CTD, RMS: PT, CMS: UK, DE |
46 | Irbesartan+Hctz | Cardiovascular System | 150+12.5, 300+12.5, 300+25mg |
Tablet | EU CTD, RMS: DE, CMS: LU |
47 | Irbesartan+Hctz | Cardiovascular System | 300+25, 300+12.5, 150+12.5mg |
Tablet | EU CTD, Reg. in DE |
48 | Ketorolac Trometamol | Ophthalmology | 5mg/ml | Eye Drop | EU CTD, RMS: UK |
49 | Latanoprost+Timolol Maleate |
Ophthalmology | 0.005%+0.5% (2.5ml) | Eye Drop | EU CTD, RMS: CZ, CMS: SK, NL, UK, HU |
50 | Levofloxacin | Anti-bacterial | 250, 500mg | Tablet | MA (UK,DE,ES,IT,HU,RO) |
51 | Memantine | Central Nervous System | 10, 20mg | Tablet | EU CTD, DCP: DE, PT |
52 | Memantine | Central Nervous System | 10, 20mg | Tablet | EU CTD, Reg. in DE |
53 | Memantine Hcl | Anti-psychotic | 10, 20 mg | Tablet | MA (PT,UK,DE,IT) |
54 | Meropenem | Carbapenems | 500, 1000mg | Injectable | EU CTD, Reg. in DE |
55 | Metformin | Anti-diabetic | 500, 850mg | Tablet | EU CTD, Reg. in UK (national) |
56 | Montelukast Sodium | Anti-Asthma | 10mg | Tablet | EU CTD, RMS: NL, CMS: UK, DE |
57 | Nebivolol | Cardiovascular System | 5mg | Tablet | EU CTD, EU – Release |
58 | Nefopam | Cardiovascular System | 30mg | Tablet | MA in the UK & Netherlands |
59 | Nitrofurantoin | Urology | 50, 100mg | Capsule | EU CTD, EU – Release |
60 | Nortriptyline | Anti-psychotic | 10, 25mg | Tablet | MA in UK and Netherland |
61 | Olmesartan | Cardiovascular System | 10, 20, 40mg | Tablet | EU CTD, Reg. in DE (DCP) |
62 | Olmesartan+Hctz | Cardiovascular System | 20+12.5, 20+25, 40+12.5, 40+25mg |
Tablet | EU CTD, Reg. in DE (DCP) |
63 | Olopatadine Hcl Solution | Ophthalmology | 0.1% (5ml) | Eye Drop | EU CTD, RMS: CZ, CMS: SK |
64 | Omeprazole | Gastroenterology | 20mg | Capsule | EU CTD, Reg. in DE |
65 | Pantoprazol (Ent. C. Tab) | Gastroenterology | 20, 40mg | Tablet | EU CTD, RMS: UK, CMS: DE |
66 | Pantoprazole | Anti-ulcers | 20, 40 mg | DR Tablet | MA (UK,DE,IT,HU,RO) |
67 | Pemetrexed | Oncology | 100, 500mg | Injectable | EU CTD, Reg. in DE |
68 | Piperacillin+Tazobactam | Antibiotics | 4.5mg | Injectable | EU CTD, EU – Release |
69 | Pregabalin | Central Nervous System | 25, 50, 75, 150, 300 mg | Capsule | EU CTD, Filed in Ireland |
70 | Pregabalin | Central Nervous System | 100mg+5ml | Syrup | EU CTD, Filed in Ireland |
71 | Rasagiline Mesylate | Central Nervous System | 1mg | Tablet | EU CTD, EU – Release |
72 | Rasagiline Tartrate | Central Nervous System | 1mg | Tablet | EU CTD, RMS: DE, CMS: LU, UK |
73 | Rivaroxaban | Cardiovascular System | 10, 15, 20mg | Tablet | EU CTD, EU – Release |
74 | Rosuvastatin | Cardiovascular System | 5, 10, 20, 40mg | Tablet | EU CTD, MA (DE, NL, ES, FR, UK, |
76 | Sildenafil | Erectile Dysfunction | 25, 50, 100mg | Tablet | MA (UK,DE,ES,IT,RO) |
77 | Sodium Cromoglicate | Ophthalmology | 2mg/ml | Eye Drop | EU CTD, RMS: UK |
78 | Sofosbuvir | Antiviral | 400mg | Tablet | EU CTD, EU – Release |
79 | Solifenacin Succinate | Urology | 5, 10mg | Tablet | EU CTD, RMS: DE, CMS: FR |
80 | Tadalafil | Erectile Dysfunction | 5, 10, 20mg | Tablet | EU CTD, EU – Release |
81 | Teicoplanin | Oncology | 200, 400mg | Injectable | EU CTD, EU – Release |
82 | Telmisartan | Cardiovascular System | 20, 40, 80mg | Tablet | EU CTD, RMS: DE, CMS: LU |
83 | Telmisartan+Hctz | Cardiovascular System | 40+12.5, 80+12.5, 80mg+25mg |
Tablet | EU CTD, RMS: DE, CMS: LU |
84 | Thioctic Acid (Ala) | Antioxidant | 600mg | Capsule | EU-COPP, EU-MfG. |
85 | Timolol | Ophthalmology | 0.25% w+v, 0.5% w+v | Eye Drop | EU CTD, RMS: UK, CMS: IE |
86 | Tolterodine Er | Urology | 2, 4mg | Capsule | EU CTD, DCP Ongoing (DE) |
87 | Topotecan | Oncology | 2.5, 4mg | Injectable | EU CTD, EU – Release |
88 | Travoprost 40 Mcg/Ml | Ophthalmology | 40 mcg/ml | Eye Drop | EU CTD, RMS: UK, CMS: DE, FR |
89 | Valsartan | Cardiovascular System | 40, 80, 160, 320mg | Tablet | EU CTD, MA (DE, IT) |
90 | Valsartan | Anti-hypertensive | 40, 80, 160, 320mg | Tablet | MA (UK,DE,IT) |
91 | Valsartan+Amlodipine | Cardiovascular System | 80+5, 160+5, 160+10mg | Tablet | EU CTD, Reg. in FR (DCP) |
92 | Valsartan+Hctz | Anti-hypertensive | 160+25 mg | Tablet | MA (UK,DE,ES,IT) |
93 | Vancomycin | Antibiotics | 500, 1000mg | Injectable | EU CTD, EU – Release |
94 | Vildagliptin | Anti-diabetic | 50mg | Tablet | EU CTD, EU – Release |
95 | Zopiclone | Anti-psychotic | 3.75, 7.5mg | Tablet | MA in the UK |
1 | Amlodipine + Atorvastatin (Caduet) | Cardio Vascular Sys. | Immediate Release | TAB | Development completed |
2 | Amlodipine + Hydrochlorothiazide + Valsartan (Exforge Hct) |
Cardio Vascular Sys. | Immediate Release | TAB | Development Completed |
3 | Amlodipine + Valsartan (Exforge) | Cardio Vascular Sys. | Immediate Release | TAB | Development Completed |
4 | Argatroban Inj (Exembol ®) | Cardio Vascular Sys. | Immediate Release | Injectable | Development completed |
5 | Atovaquone Oral Suspension (Mepron®) | Antibiotic | Immediate Release | Suspension | Development under progress |
6 | Azithromycin Tablet (Zithromax®) | Antibiotic | Immediate Release | TAB | Development Completed |
7 | Aztreonam Injection (Azactam®) | Antibiotic | Immediate Release | Injectable | Development under progress |
8 | Bromhexine + Guaifenesin (Benadryl Chesty Forte) |
Cough | Immediate Release | Liquid | Development completed |
9 | Candesartan Cilexetil (Atacand) | Cardio Vascular Sys. | Immediate Release | TAB | Development Completed |
10 | Candesartan Cilexetil + Hydrochlorothiazide (Hytacand) |
Cardio Vascular Sys. | Immediate Release | TAB | Development Completed |
11 | Carbamazepine ER Tablets (Tegretol® Xr) | Epilepsy | Modified Release | TAB | Development under progress |
12 | Carbamazepine Ir (0) | CNS | Immediate Release | Tablet | Development under progress |
13 | Carbamazepine Pr (0) | CNS | Immediate Release | Tablet | Development under progress |
14 | Cetirizine Oral Drops (0) | Anti-Histamine | Immediate Release | Drops | Development under progress |
15 | Clobazam IR Tablet (Onfi®) | Anti-Convulsant | Immediate Release | TAB | Development under progress |
16 | Clobazam Oral Suspension (Onfi®) | Anti-Convulsant | Immediate Release | Suspension | Development under progress |
17 | Clozapine IR Tablet (Clozaril®) | Schizophrenia | Immediate Release | TAB | Development under progress |
18 | DabigatranCapsule (Pradaxa®) | Cardio Vascular Sys. | Modified Release | CAPS | Development under progress |
19 | Deferasirox Tablet for Suspension (Exjade®) |
Iron Chelator | Immediate Release | TAB | Development Completed |
20 | DexmedetomidineInjection (Precedex®) | Sedative | Immediate Release | Injectable | Development under progress |
21 | Diclofenac Potassium (0) | Pain | Immediate Release | Tablet | Development under progress |
22 | Diclofenac Sodium ER (0) | Pain | Immediate Release | Tablet | Development under progress |
23 | Diclofenac Sodium Gastro Resistant Tablets (0) |
Pain | Immediate Release | Tablet | Development under progress |
24 | Esomeprazole/Omeprazole | Heartburn | Immediate Release | Capsule | Development completed |
25 | Ezetemibe Tablet (Zetia®) | Cholesterol Lowering |
Immediate Release | TAB | Development Completed |
26 | Ezetimibe + Simvastatin Tablet (Vytorin®) |
Cholesterol Lowering |
Immediate Release | TAB | Development Completed |
27 | Febuxostat (0) | Anti-Gout | Immediate Release | Tablet | Development under progress |
28 | FingolimodCapsules (Gilenya®) | Multiple sclerosis | Immediate Release | CAPS | Development Completed |
29 | Glucosamine + Condroitin + Krill Oil |
Calcium & Vit D3 | Immediate Release | Softgel | Development completed |
30 | Haloperidol Decanoate Inj (Haldol®) | Antipsychotic | Modified Release | Injectable | Development under progress |
31 | Hedera Helix + Lactoferrin (0) | Cough | Immediate Release | Liquid Paed | Development under progress |
32 | Hyoscine Butylbromide (Buscopan) | Abdomen Cramps | Immediate Release | Tablet | Development completed |
33 | Ibuprofen + Phenylephrine (Ascorbic Acid) (Fdc) |
Sinus Pain | Immediate Release | Tablet, Powder |
Development completed |
34 | Kelp + Chromium + Vit B + Others |
Hypothyroidism | Immediate Release | Tablet | Development completed |
35 | Lacosamide Oral Solution (Vimpat®) | Seizures | Immediate Release | Solution | Development completed |
36 | Lansoprazole Gastro Resistant (Lanzor) |
GI | Modified Release | CAPS | Development Completed |
37 | Levitiracetam (Keppra) | Epilepsy | Immediate Release | Solution | Development completed |
38 | Loratidine Chewable Tablet (Claritin®) | Anti Allergic | Immediate Release | TAB | Development Completed |
39 | MedroxyprogesteroneInj (Depo- Provera®) |
Female Hormone | Modified Release | Injectable | Development Completed |
40 | Metformin (Metformin Rosemont) |
Anti-Diabetic | Immediate Release | Solution | Development under progress |
41 | Metformin ER Tablets (Glumetza®) | Anti-Diabetic | Modified Release | TAB | Development under progress |
42 | Metformin XR (0) | Anti-Diabetic | Immediate Release | Tablet | Development under progress |
43 | Methocarbamol Inj (Robaxin®) | Muscle relaxant | Immediate Release | Injectable | Development under progress |
44 | Montelukast | Allergy | Immediate Release | Chew Tab | Development completed |
45 | Nitrofurantoin (Furdantin) | Antibiotic | Immediate Release | Suspension | Development completed |
46 | NitrofurantoinCapsule (Macrodentin®) | Antibiotic | Immediate Release | CAPS | Development under progress |
47 | Omeprazole For Suspension (Zegrid, Santarus) |
GI | Immediate Release | Powder | Development under progress |
48 | Omeprazole For Suspension SF (Zegrid, Santarus) |
GI | Immediate Release | Powder | Development under progress |
49 | Oxcarbazepine Oral Suspension (Trileptal®) |
Anti-Convulsant | Immediate Release | Suspension | Development under progress |
50 | Paracetamol + Hyoscine (Buscopan Venus) Butylbromide |
Period Cramps | Immediate Release | Tablet | Development completed |
51 | Paracetamol + Phenylephrine + Caffeine (Lemsip, Tylenol) |
Cold & Flu | Immediate Release | Tablet, Powder |
Development completed |
52 | Paracetamol + Phenylephrine + Dextromethorphan (Codral / Robitussin Severe) |
Cold & Flu | Immediate Release | Tablet, Liquid | Development completed |
53 | Paracetamol + Phenylephrine + Dextromethorphan + Chlorphenamine (Dimetapp / Codral / Robitussin Severe) |
Cold & Flu | Immediate Release | Tablet, Liquid | Development completed |
54 | Paracetamol + Phenylephrine + Fexofenadine (Allegra D / Zyttec D) |
Cold & Flu | Modified Release | SR Tablet | Development completed |
55 | Potassium chloride (matrix) tablets (K-Tab®) |
GI | Modified Release | TAB | Development under progress |
56 | Potassium Chloride Dispersible ER (Klor-Con® M) |
GI | Modified Release | TAB | Development Completed |
57 | ProchlorperazineInj (Na) | Antipsychotic | Immediate Release | Injectable | Development under progress |
58 | Propofol Inj (Diprivan®) | Cardio Vascular Sys. | Immediate Release | Injectable | Development completed |
59 | Ranolazine Tablets ER (Ranexa®) | Cardio Vascular Sys. | Modified Release | TAB | Development Completed |
60 | Sitagliptin + Metformin Tablet IR (Janumet®) |
Anti-Diabetic | Immediate Release | TAB | Development Completed |
61 | Sitagliptin Tablet (Januvia®) | Anti-Diabetic | Immediate Release | TAB | Development Completed |
62 | Tacrolimus (Prograf) | Immunosuppressan t |
Immediate Release | CAPS | Development Completed |
63 | Telmisartan (Micardis) | Cardio Vascular Sys. | Immediate Release | TAB | Development Completed |
64 | Telmisartan + Amlodipine (Twynsta) | Cardio Vascular Sys. | Immediate Release | TAB | Development Completed |
65 | Telmisartan + Hydrochlorothiazide (Micardis Hct) |
Cardio Vascular Sys. | Immediate Release | TAB | Development Completed |
66 | Ticagrelor Tablet (Brilinta®) | Cardio Vascular Sys. | Immediate Release | TAB | Development under progress |
List of Nutraceutical Products
# | Product | Therapeutic Area | Strength | Form | Comments |
1 | Alfa Gmood Classic | Mood & Anti-stress | Saffron 15mg | Tablet, capsule, sachet or soft gel capsules |
> Patented ingredient > Benefits in 2-capsules per day > Pending EU EFSA claims > EU Manufactured & registered |
2 | Alfa Gmood Flash | Mood & Anti-stress | Saffron 30mg (stick of 400mg) |
Tablet, capsule, sachet or soft gel capsules |
> Patented ingredient > Benefits within 20 minutes > Pending EU EFSA claims > EU Manufactured & registered |
3 | Alfa Gmood Flavored | Mood & Anti-stress | Saffron 30mg (sachet of 3,5g) + flavoring agents |
Tablet, capsule, sachet or soft gel capsules |
> Patented ingredient > Benefits within 20 minutes > Pending EU EFSA claims > EU Manufactured & registered |
4 | Alfa Pmens Comfort | Women’s Health (Premenstrual) | Saffron 35mg, Yarrow, Feverfew, Hibiscus |
Tablet, capsule, sachet or soft gel capsules |
> Patented ingredient > Pending EU EFSA claims > Benefits with 4-natural compounds > EU Manufactured & registered |
5 | Alfa MagSleep | Sleep | Magnesium, lemon Chamomile, grape |
Balm | > Patented lemon balm extract > EU EFSA claims > EU Manufactured & registered |
6 | Alfa Skin Classic | Skin | New generation anti-aging formula (Grape flavanol – monomers & OPC, SOD, |
Soft gel capsules (Veg.) |
> Patented ingredient & Proven clinical studies > EU Manufactured & registered |
7 | Alfa Memo Classic | Cognitive Health | Twice patent-pending formula (Grape + blueberry) 150mg |
Capsule | > Patented ingredient & Proven clinical studies > Benefits in 2-capsules per day > EU EFSA claims > EU Manufactured & registered > Awarded formula at various |
8 | Alfa Memo Booster | Cognitive Health | Twice patent-pending formula (Grape + blueberry) 150mg, Bacopa, Vitamin B12, Iodine |
Tablet | > Patented ingredient & Proven clinical studies > Benefits in 2-capsules per day > Pending EU EFSA claims > EU Manufactured & registered > Awarded formula at various conferences |
9 | Alfa iCare | Ophthalmics (Vision care): For macular degeneration,Retino pathy and Other degenerative eye diseases |
Lutein 6mg + Zeaxanthin 1mg | Soft gel | EU Manufactured & registered |
10 | Alfa Autis | Mental Health and Neuro regeneration: For improvement of cognitive Skills, Eyesight, Mental Strength |
L-Carnosine 100mg + Docosahexaenoic Acid 5mg (DHA) |
Syrup | > EU Manufactured & registered > Clinical studies available |
11 | Alfa iKid | Mental Health and Neuro regeneration: For improvement of cognitive Skills, Eyesight, Mental Strength |
DHA 200 mg, Vitamin D 200 IU, Vitamin B12(Methylcobalamin) 3 mcg, Vitamin B1(Thiamine) 1 mg, Vitamin B2(Riboflavin) 1 mg, Vitamin B6 (Pyrodoxine) 1,9 mcg, Nicotinamide 20 mg |
Soft gel | EU Manufactured & registered |
12 | Alfa UroMax | Supports prostate functions | Curcuma Longa extract 500 mg + Piper Longam extract + 5 mg |
Tablet | EU Manufactured & registered |
13 | Alfa Calcicare | Bone & Joint care: New generation calcium Supplement | Calcium citrate maleate 1630mg, Folic Acid 200mcg, Vit D3 200I.U., Iodine 75mcg, Zinc 7.5mg, Magnesium 50mg |
Tablet | EU Manufactured & registered |
14 | Alfa RenoCare | Supports renal function | SODIUM COPPER CHLOROPHYLLIN | Syrup | > EU Manufactured & registered > Clinical studies available > Patented formulation > Available under Alfa brand |
15 | Alfa Flex | Bone & Joint care: For Arthritis and joint pains | Crystalline Glucosamine Suphate 500mg, Chondriotin Suphate Sodium 250mg, Standardized Bosewella Serrata extract 100mg, Standardized Curcuma Longa Extract 100mg, Piper Longam 5mg |
Tablet | EU Manufactured & registered |
List of Medicinal Medical Devices
# | Product | Therapeutic Area | Strength | Form | Comments |
1 | Alfa iDrops Monodose BFS | Ophthalmics | Sodium Hyaluronate 0.88mL/strip | Blow Fill Seal (B.F.S) | > Eye Drops for dry eye syndrome > Preservative free single-use artificial eye drops > EU approved class IIa medical device > EU Manufactured & registered > Shelf life of 36 months |
2 | Alfa iDrops Monodose or Multidose |
Ophthalmics | Perilla dry extract and Sodium Hyaluronate 0,1% |
> Single dose container of 0,5 ml > Multidose preservativ e bottle of 10ml |
> Intended to relieve eyes from redness, dryness and tiredness caused by environmental agents (such as dust, allergens as well as ocular stress (due to prolonged use of the computer, long time wearing of contact lenses, excessive exposure to light). Perilla is well known for its anti-oxidant properties. Can be used with contact lenses. > EU approved class IIa Medical Device > EU Manufactured & registered > Shelf life of 36 months |
3 | Alfa iDrops Monodose | Ophthalmics | Perilla dry extract and Sodium Hyaluronate 0,25% |
Single dose container of 0,5 ml | > Light viscosity. Intended to relieve eyes from redness, dryness and tiredness caused by environmental agents as well as ocular stress. Also intended to alleviate the eye dryness sensation occasionally related to a blepharitis and to prevent situations of allergic conjunctivitis. Can be used with contact lenses. > EU approved class IIa Medical Device > EU Manufactured & registered > Shelf life of 36 months |
4 | Alfa iDrops Monodose or Multidose |
Ophthalmics | Distilled waters of Blueberry, Chamomile, Euphrasia, |
> Single dose container: 0,5 ml > Multidose preservativ e bottle of 10ml |
Low viscosity. Intended to refresh, hydrate, lubricate and soothe situations of redness, tiredness and ocular discomfort caused by environmental agents (such as dust, allergens) as well as ocular stress (due to prolonged use of computer, long time wearing of contact lenses and excessive exposure to light). Recommended to give immediate relief in case of dry eyes and for frequent and prolonged use. Can be used with contact lenses. > EU approved class IIa Medical Device > EU Manufactured & registered > Shelf life of 36 months |
5 | Alfa Nspray (Preservative free Alcohol free Propellant free & Gluten free) |
Nasal spray | Hyaluronic acid and vegetal extracts of Perilla Frutescens, Echinacea Angustifolia and Polygonum Cuspidatum |
Spray – 20ml bottle with APF system to maintain sterility after first openin |
> > Indicated in case of allergic rhinitis and upper respiratory tract infections and for the cleaning of the nasal cavity. The hypertonia of the solution and the hyaluronic acid help the fluidisation and removal of the mucus, restoring the mucociliary clearance. The combination of hyaluronic acid with the vegetal extracts performs a soothing and antioxidant action and protects the nasal mucosa from external irritant agents such as smoke, dust, dry air and pollens. > EU approved class IIa Medical Device > EU Manufactured & registered > Shelf life of 36 months |
6 | Alfa Nspray (Preservative free Alcohol free Propellant free & Gluten free) |
Nasal spray | Hyaluronic acid, Tween80 and EDTA in hypertonic, |
Spray – 20ml bottle with APF system to maintain sterility after first openin |
> Indicated for the cleaning of the nasal cavity and effectively removes the bacterial biofilm typical in chronic rhinosinusitis and upper respiratory tract infections restoring the mucociliary clearance. > The hyaluronic acid performs a moisturizing and soothing action alleviating the dryness of the mucosa and protecting it from external irritant agents such as smoke, dust, dry air and pollens. > EU approved class IIa Medical Device > EU Manufactured & registered > Shelf life of 36 months |
7 | Alfa iSmoke | Nictotine Replacement Therapy |
Hamamelis and Sodium Hyaluronate 0,15% |
Lozenges | > EU approved class l medical device > 2 clinical studies > 10 years of research data |
8 | Alfa iRelieve | Acute / Chronic Diarrhoea for adults and child >1y | Diosmectite 5.25g Sachet | Sachet | > EU approved class lla medical device > EU Manufactured & registered |
9 | Alfa iRelieve Plus | Acute / Chronic Diarrhoea for adults and child >1y | Diosmectite + prebiotic fibres: 5.25g Sachet |
Sachet | > EU approved class lla medical device > EU Manufactured & registered |
10 | Alfa iSmec | Treats excess wind, stomach bloating and cramping |
Simethicone & Active Carbon |
Tablet | > EU approved class lla medical device > EU Manufactured & registered |
11 | Alfa iSeal | Dermatology | N-Butyl-2- Cyanoacrylate): 0,25ml or 0,5ml (for surgicals) |
Vial | > CE certified class lla medical device > EU registration (Q3.2019) |
12 | Alfa vCare | Vaginal care | Lactobacillus & Lactic acid |
Tablet | > EU approved class lla medical device > EU Manufactured & registered |
List of Over the Counter (OTC) drugs
# | Product | Therapy | Strength | Dosage form | Status |
1 | Amylmetacresol + 2,4-Dichlorobenzyl Alcohol + Lidocaine Hcl | SoreThroat | 0.6mg + 1.2mg + 10mg |
Lozenge (Menthol/ Orange/ Honey Lemon) |
EU-COPP, EU-MfG. |
2 | Amylmetacresol +Dichlorobenzyl alcohol | SoreThroat | 0.6mg + 1.2mg | Lozenge (Orange/Honey Lemon/Menthol/ Eu calyptus/Regular/ Pineapple/Lemon) |
EU-COPP, EU-MfG. |
3 | Benzydamine Hcl + 2,4-Dichlorobenzyl Alcohol + Lidocaine Hcl | SoreThroat | 3mg + 1.2mg + 4mg | Lozenge (Blackcurrant/ Honey Lemon/ Berry/ Eucalyptus/ Menthol) |
EU-COPP, EU-MfG. |
4 | Benzydamine Hcl + Cetylpyridinium Chloride | SoreThroat | 3mg + 1.33mg | Lozenge (Honey Lemon/ Orange/ Raspberry/ Double Mint) |
EU-COPP, EU-MfG. |
5 | Bromhexine Hcl + Cetylpyridinium Chloride | SoreThroat | 8mg + 1.33mg | Lozenge (Lemon/ Eucalyptus/ Menthol) |
EU-COPP, EU-MfG. |
6 | Cetirizine | Allergy | 10mg | Tablet | EU CTD, EU – Release |
7 | Cetirizine (Drops) | Allergy | 10mg + ml, 20ml | Drops | EU CTD, EU – Release |
8 | Cetirizine (Liquid) | Allergy | 5mg + 5ml, 200ml | Liquid | EU CTD, EU – Release |
9 | Desloratadine | Allergy | 5mg | Tablet | EU CTD, EU – Release |
10 | Desloratadine (Liquid) | Allergy | 2.5mg + 5ml, 200ml | Liquid | EU CTD, EU – Release |
11 | Dextromethorphan | Cough | 2mg + ml | Liquid (Bottle & Stick Pack) | EU-COPP, EU-MfG. |
12 | Dextromethorphan | Cough | 15mg | Tablet | EU-COPP, EU-MfG. |
13 | Dextromethorphan | Cough | 1mg + ml | Liquid Paed | EU-COPP, EU-MfG. |
14 | Diclofenac + Thiamine HCL + PyridoxineHcl + Cyanocobalamine |
Pain | 50mg+50mg+ 50mg+0.25m g |
Tablet | EU-COPP, EU-MfG. |
15 | Dimenhydrinate Adult | Kinetic Sickness | 50 mg | Stick Pack (Liquid) | EU-COPP, EU-MfG. |
16 | Dimenhydrinate Junior | Kinetic Sickness | 12.5 mg | Stick Pack (Liquid) | EU-COPP, EU-MfG. |
17 | Doxylamine | Sleep | 12.5, 25mg | Tablet | EU-COPP, EU-MfG. |
18 | Flurbiprofen | SoreThroat | 8.75mg | Lozenge (Honey Lemon) | EU-COPP, EU-MfG. |
19 | Flurbiprofen Sugar Free | SoreThroat | 8.75mg | Lozenge (Orange) | EU-COPP, EU-MfG. |
20 | Hedera Helix | Cough | 35mg + 5ml | Liquid Paed | EU-COPP, EU-MfG. |
21 | Hexylresorcinol | SoreThroat | 2.4mg | Lozenge (Blackcurrant/Honey Lemon) | EU-COPP, EU-MfG. |
22 | Ibuprofen + Paracetamol | Pain & Fever | 200mg+500mg | Tablet | EU CTD, EU – Release |
23 | Ibuprofen + Paracetamol + Doxylamine | Pain & Fever | 200mg+500mg+5mg | Tablet | EU CTD, EU – Release |
24 | Ibuprofen Lysine | Pain | 400mg | Pow. for Sol. | EU-COPP, EU-MfG. |
25 | Ibuprofen Lysine | Pain | 100mg + 5ml, 120ml | Suspension | EU-COPP, EU-MfG. |
26 | Ibuprofen lysine | Pain | 400 mg, 600 mg (Rx) | Powder for Solution | EU-COPP, EU-MfG. |
27 | Ibuprofen lysine | Pain | 100 mg/5 ml, 120 ml | Suspention | EU-COPP, EU-MfG. |
28 | Ibuprofen Sodium Dihydrate | Pain | 256mg, 512mg | Tablet | EU CTD, EU – Release |
29 | Iron III Polymaltose Complex | Iron Deficiency | 35.7 mg/mg | Syrup | EU-COPP, EU-MfG. |
30 | Iron III Polymaltose Complex + Folic Acid | Iron Deficiency | 100 mg/0,35 mg | Chewable Tablet | EU-COPP, EU-MfG. |
31 | Oxymetazoline – Nasal spray solution | Nasal Congestion | 0.5mg + ml | Nasal Spray | EU-COPP, EU-MfG. |
32 | Paracetamol + Dextromethorphan + Chlorphenamine | Cold & Flu | 300mg+15mg+2mg | Powder For Susp | EU-COPP, EU-MfG. |
33 | Paracetamol + Dextromethorphan + Chlorphenamine | Cold & Flu | 300 + 15 + 2mg | Stick Pack (Granules) | EU-COPP, EU-MfG. |
34 | Paracetamol + Dextromethorphan + Chlorphenamine + Pseudoephedrine | Cold & Flu | 500mg+15mg+ 2mg+30 mg |
Capsule | EU-COPP, EU-MfG. |
35 | Paracetamol + Phenylephrine + Chlorphenamine | Cold & Flu | 650mg+15.58mg+ 4mg 1000mg+15.58mg+ 4mg |
Granules For Susp | EU-COPP, EU-MfG. |
36 | Paracetamol + Phenylephrine + Chlorphenamine | Cold & Flu | 650 + 15.58 + 4mg 1000 + 15.58 + 4mg |
Stick Pack (Granules) | EU-COPP, EU-MfG. |
37 | Pholcodine BP + Cetylpyridinium Chloride BP | SoreThroat | 5.5mg + 1.33mg | Lozenge (Lemon/ Orange) | EU-COPP, EU-MfG. |
38 | Sodium alginate + Sodium hydrogen carbonate + Calcium carbonate | Heartburn | 500mg + 267mg + 160mg | Suspension of 10ml/sachet | EU-COPP, EU-MfG. |
39 | Sodium alginate + Sodium hydrogen carbonate + Calcium carbonate | Heartburn | 500mg + 267mg + 160mg, 150 ml |
Oral Suspension | EU-COPP, EU-MfG. |